Dapagliflozin 3-O-β-D-glucuronide

Product Description
CAT No.
ALN-D015093
CAS No.
1351438-75-9
Mol. F.
C27H33ClO12
Mol. Wt.
585
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : (2S,3S,4S,5R,6R)-6-(((2S,3S,4R,5R,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-3,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
Smiles : O[C@H]([C@H]([C@@H]1O)O[C@@H]([C@@H]([C@H]2O)O)O[C@@H]([C@H]2O)C(O)=O)[C@@](C(C=C3)=CC(CC(C=C4)=CC=C4OCC)=C3Cl)([H])O[C@@H]1CO
Inchi : InChI=1S/C129H215N33O55/c1-18-59(10)98(159-114(201)76(36-42-91(181)182)146-120(207)83(53-164)154-121(208)84(54-165)155-127(214)99(63(14)166)160-118(205)80(51-94(187)188)152-123(210)95(56(4)5)156-104(191)62(13)135-102(189)60(11)137-115(202)78(49-92(183)184)151-119(206)82(52-163)138-66(17)169)125(212)161-101(65(16)168)128(215)162-100(64(15)167)126(213)147-70(30-22-26-46-133)109(196)150-79(50-93(185)186)117(204)149-77(47-55(2)3)116(203)142-69(29-21-25-45-132)108(195)144-73(33-39-88(175)176)110(197)141-67(27-19-23-43-130)106(193)140-68(28-20-24-44-131)107(194)145-75(35-41-90(179)180)113(200)157-97(58(8)9)124(211)158-96(57(6)7)122(209)148-74(34-40-89(177)178)111(198)143-71(31-37-86(171)172)105(192)136-61(12)103(190)139-72(32-38-87(173)174)112(199)153-81(129(216)217)48-85(134)170/h55-65,67-84,95-101,163-168H,18-54,130-133H2,1-17H3,(H2,134,170)(H,135,189)(H,136,192)(H,137,202)(H,138,169)(H,139,190)(H,140,193)(H,141,197)(H,142,203)(H,143,198)(H,144,195)(H,145,194)(H,146,207)(H,147,213)(H,148,209)(H,149,204)(H,150,196)(H,151,206)(H,152,210)(H,153,199)(H,154,208)(H,155,214)(H,156,191)(H,157,200)(H,158,211)(H,159,201)(H,160,205)(H,161,212)(H,162,215)(H,171,172)(H,173,174)(H,175,176)(H,177,178)(H,179,180)(H,181,182)(H,183,184)(H,185,186)(H,187,188)(H,216,217)/t59-,60-,61-,62-,63+,64+,65+,67-,68-,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,80-,81-,82-,83-,84-,95-,96-,97-,98-,99-,100-,101-/m0/s1
Technical Data
Reference
Stability indicating rp-hplc method for simultaneous estimation of dapagliflozin and saxagliptin in pharmaceutical dosage forms
By Thota, Hanisha; Soundarya, G.nFrom Journal of Global Trends in Pharmaceutical Sciences (2021), 12(1), 9131-9137
Method development and validation of a stability-indicating reversed-phase liquid chromatographic method for the simultaneous estimation of metformin and dapagliflozin in presence of their degradation products
By Kotecha, Nidhi; Patel, Jayvadan – From International Journal of Pharmaceutical Sciences Review and Research (2019), 56(2), 1-6.
Validation of a newly developed stability indicating RP-liquid chromatographic method for the quantitative determination of dapagliflozin
By Sura, Sreenivasulu; Modalavalasa, Rameswara Rao; Kothapalli, ChandraSekhar B. – From Pharma Chemica (2018), 10(1), 93-102
RFQ